Syracuse, NY – Upstate Medical University began injecting people today with the Covid-19 experimental vaccine as part of a large study by drug company Pfizer that will include 30,000 people in the United States, Brazil, Argentina and the United States. Germany.
Upstate is one of 62 research centers nationwide participating in the study. You are looking for volunteers to participate in the study to evaluate the safety and performance of the potential vaccine.
Four people received the vaccine at a Station this morning, said Dr. Tim Endy, president of microbiology and immunology at States.
There are no approved vaccines to prevent Covid-19 that has been spreading worldwide since the beginning of this year.
Pfizer is developing its potential vaccine with BioNTech, a German company. There are many other companies rushing to come up with the vaccine as the US beats with an increase in Covid-19 cases.
Modern, a Massachusetts biotechnology company, began a large clinical trial in the United States this week of another Covid-19 vaccine.
The federal government has agreed to pay $ 1.95 billion to buy 100 million doses of Pfizer vaccine by the end of this year if the study shows it is safe and effective. The agreement was signed as part of Operation Warp Speed, the Trump administration’s effort to accelerate the development and production of vaccines and treatments to fight the new coronavirus.
Anthony Fauci, the federal government’s top infectious disease expert, said Tuesday that he is “optimistic with caution” a viable Covid-19 vaccine may be available by this fall.
Pfizer said its potential vaccine has emerged as a strong candidate based on safety assessments and its immune response. The company said in a statement that there were no serious adverse events among the 120 people who received the vaccine in a previous study. He said mild to moderate side effects of the experimental vaccine included fever, fatigue and cold.
The Upstate study will be done at random. This means that some participants receive placebo and others, the potential of the vaccine. The majority of the study team do not know which individuals are receiving the placebo or the experimental vaccine.
To be eligible for the study, individuals must be healthy, between 18 and 85 years old and be able to make a two-year commitment to study. Volunteers will be required to provide blood samples up to two years after receiving the vaccine / placebo. Individuals may appear up to ten times during the two-year study period. The two-year time frame for the study is important to assess safety and long-term immune response.
Updated said that individuals will be compensated for their participation and will not incur any costs for participation in the study.
Individuals who have previously tested positive for Covid-19 are not eligible to participate. Blood tests can show if the vaccine triggers an immune response in participants who can fight the virus.
During their first two study visits, participants receive the study vaccine or placebo injection. Nose strains to test Covid-19 will also be collected at these times. Blood samples should be taken during other study visits to be followed.
For seven days after receiving the placebo / study vaccine, participants will be required to keep a daily record of any specific reactions.
Individuals interested in participating in the study can call 315-464-9869 or email firstname.lastname@example.org for more information.
James T. Mulder covers health news. Do you have a news tip? Contact him at (315) 470-2245 or email@example.com